The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

REPL FINANCIAL STATEMENTS

Replimune Group Inc — balance sheet, income statement and cash flow trends

REPLReplimune Group Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-300 M-200 M-100 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-3.3 M $ · -Infinity%Operating Income-297.7 M $ · -Infinity%Pre-tax Income-297.6 M $ · -Infinity%Net Income to Owners-297 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-3.3 M $—
Operating Income-297.7 M $—
EBITDA-291.1 M $—
Net Income to Owners-297 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets252.4 M
  • Equity105.6 M $42%
  • Current Liabilities38.4 M $15%
  • Long-term Liabilities108.4 M $43%

Key Figures

YoY change
Total Assets252.4 M $-46.2%
Total Liabilities146.8 M $+10.6%
Total Equity105.6 M $-68.6%
Cash & ST Investments195.3 M $-51.6%
Total Debt112 M $+46.7%
Net Debt-73.4 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0100 M-279.1 M $Operating295.8 M $Investing67.3 M $Financing84 M $Net Change

Key Figures

YoY change
Operating Cash Flow-279.1 M $—
Capital Expenditures1.5 M $-80.8%
Free Cash Flow-280.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on REPL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.